Insight & Updates

Insights & Updates

Insights, Research & Industry Updates

New Radiochemical Lab to Support Next-Gen Cancer Treatment

National University of Singapore (NUS) Yong Loo Lin School of Medicine – Clinical Imaging Research Centre (CIRC) and Cyclotek Announce Strategic Collaboration to Strengthen Radiopharmaceutical Capability in Singapore and Across ASEAN

CYCLOTEK’S NEW CEO SIGNALS EXPANSION INTO WESTERN AUSTRALIA

Cyclotek and Duchembio announce APAC extension of the license agreement for [18F]FP-CIT for the diagnosis of neurodegenerative disorders

Cyclotek Awarded CRC-P Round 16 Grant to Advance Nanobody-Based Theranostic Platform for Cancer

Cyclotek Enables First in Human Company-Sponsored Trial with Terbium-161 Radiopharmaceutical in Australia

Cyclotek Drives Innovation in Radiopharmaceuticals with Cutting-Edge Facilities in Victoria

Cyclotek Expands Radiopharmaceutical Capacity in Queensland: A New Era for Imaging and Therapy Providers

Cyclotek and the University of Melbourne sign Strategic Partnership Agreement